nodes	percent_of_prediction	percent_of_DWPC	metapath
Carboprost Tromethamine—PTGFR—corpus luteum—polycystic ovary syndrome	0.174	0.443	CbGeAlD
Carboprost Tromethamine—PTGFR—ovarian follicle—polycystic ovary syndrome	0.136	0.346	CbGeAlD
Carboprost Tromethamine—PTGER1—female gonad—polycystic ovary syndrome	0.0144	0.0368	CbGeAlD
Carboprost Tromethamine—PTGER1—endocrine gland—polycystic ovary syndrome	0.0134	0.0343	CbGeAlD
Carboprost Tromethamine—PTGFR—uterus—polycystic ovary syndrome	0.0124	0.0316	CbGeAlD
Carboprost Tromethamine—PTGFR—adipose tissue—polycystic ovary syndrome	0.0121	0.0309	CbGeAlD
Carboprost Tromethamine—Bimatoprost—PTGER3—polycystic ovary syndrome	0.0119	0.369	CrCbGaD
Carboprost Tromethamine—PTGFR—adrenal gland—polycystic ovary syndrome	0.0109	0.0277	CbGeAlD
Carboprost Tromethamine—PTGFR—female gonad—polycystic ovary syndrome	0.0101	0.0258	CbGeAlD
Carboprost Tromethamine—PTGFR—endocrine gland—polycystic ovary syndrome	0.00942	0.024	CbGeAlD
Carboprost Tromethamine—Dinoprost Tromethamine—PTGER3—polycystic ovary syndrome	0.00719	0.223	CrCbGaD
Carboprost Tromethamine—Dinoprostone—PTGER3—polycystic ovary syndrome	0.00553	0.172	CrCbGaD
Carboprost Tromethamine—Respiratory distress—Metformin—polycystic ovary syndrome	0.00502	0.105	CcSEcCtD
Carboprost Tromethamine—Bimatoprost—AKR1C3—polycystic ovary syndrome	0.00498	0.155	CrCbGaD
Carboprost Tromethamine—Chest discomfort—Metformin—polycystic ovary syndrome	0.0036	0.0755	CcSEcCtD
Carboprost Tromethamine—Lightheadedness—Metformin—polycystic ovary syndrome	0.00285	0.0598	CcSEcCtD
Carboprost Tromethamine—Lethargy—Metformin—polycystic ovary syndrome	0.00236	0.0495	CcSEcCtD
Carboprost Tromethamine—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00211	0.0443	CcSEcCtD
Carboprost Tromethamine—Sweating increased—Metformin—polycystic ovary syndrome	0.00195	0.0408	CcSEcCtD
Carboprost Tromethamine—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00186	0.039	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.0018	0.00341	CbGpPWpGaD
Carboprost Tromethamine—Drowsiness—Metformin—polycystic ovary syndrome	0.00178	0.0374	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—polycystic ovary syndrome	0.00177	0.00335	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.00176	0.00334	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—polycystic ovary syndrome	0.00173	0.00328	CbGpPWpGaD
Carboprost Tromethamine—Dinoprostone—CYP11A1—polycystic ovary syndrome	0.00171	0.0532	CrCbGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.00165	0.00312	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.00161	0.00305	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.0016	0.00304	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.0016	0.00304	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.00158	0.003	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.00157	0.00297	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.00157	0.00297	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.00155	0.00294	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.00154	0.00292	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.00151	0.00286	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.0015	0.00284	CbGpPWpGaD
Carboprost Tromethamine—Flushing—Metformin—polycystic ovary syndrome	0.00149	0.0311	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00147	0.00278	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.00146	0.00276	CbGpPWpGaD
Carboprost Tromethamine—Chills—Metformin—polycystic ovary syndrome	0.00144	0.0301	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.00143	0.0027	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00142	0.00268	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00141	0.00267	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.0014	0.00265	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00139	0.00263	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00138	0.00261	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.00137	0.00259	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.00136	0.00257	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.00134	0.00254	CbGpPWpGaD
Carboprost Tromethamine—Muscle spasms—Metformin—polycystic ovary syndrome	0.00134	0.0281	CcSEcCtD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—GHRL—polycystic ovary syndrome	0.00134	0.00253	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.00133	0.00252	CbGpPWpGaD
Carboprost Tromethamine—Vision blurred—Metformin—polycystic ovary syndrome	0.00131	0.0275	CcSEcCtD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.00131	0.00249	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00131	0.00248	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—GHRL—polycystic ovary syndrome	0.00131	0.00248	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00128	0.00243	CbGpPWpGaD
Carboprost Tromethamine—Syncope—Metformin—polycystic ovary syndrome	0.00125	0.0262	CcSEcCtD
Carboprost Tromethamine—Palpitations—Metformin—polycystic ovary syndrome	0.00123	0.0258	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00122	0.0257	CcSEcCtD
Carboprost Tromethamine—Hypertension—Metformin—polycystic ovary syndrome	0.0012	0.0252	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.0012	0.00227	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—polycystic ovary syndrome	0.0012	0.00226	CbGpPWpGaD
Carboprost Tromethamine—Chest pain—Metformin—polycystic ovary syndrome	0.00119	0.0249	CcSEcCtD
Carboprost Tromethamine—Myalgia—Metformin—polycystic ovary syndrome	0.00119	0.0249	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00117	0.00222	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.00117	0.00222	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—polycystic ovary syndrome	0.00117	0.00222	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00115	0.00218	CbGpPWpGaD
Carboprost Tromethamine—Infection—Metformin—polycystic ovary syndrome	0.00113	0.0237	CcSEcCtD
Carboprost Tromethamine—Shock—Metformin—polycystic ovary syndrome	0.00112	0.0234	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.0011	0.023	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00109	0.00206	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00107	0.00203	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00106	0.00201	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00105	0.00199	CbGpPWpGaD
Carboprost Tromethamine—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00104	0.0217	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00103	0.00196	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00102	0.00193	CbGpPWpGaD
Carboprost Tromethamine—Paraesthesia—Metformin—polycystic ovary syndrome	0.00102	0.0214	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Metformin—polycystic ovary syndrome	0.00101	0.0212	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00101	0.00192	CbGpPWpGaD
Carboprost Tromethamine—Somnolence—Metformin—polycystic ovary syndrome	0.00101	0.0212	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—LHB—polycystic ovary syndrome	0.001	0.00189	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.000998	0.00189	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—NPB—polycystic ovary syndrome	0.000986	0.00187	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.000982	0.00186	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.000977	0.00185	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—NPB—polycystic ovary syndrome	0.000965	0.00183	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000962	0.00182	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000962	0.00182	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.000961	0.00182	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—SCT—polycystic ovary syndrome	0.000957	0.00181	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000941	0.00178	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000941	0.00178	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—SCT—polycystic ovary syndrome	0.000937	0.00177	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000913	0.00173	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.000906	0.00172	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.000906	0.00172	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000894	0.00169	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000892	0.00169	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.000887	0.00168	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.000887	0.00168	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000885	0.00168	CbGpPWpGaD
Carboprost Tromethamine—Dinoprostone—CYP19A1—polycystic ovary syndrome	0.000885	0.0275	CrCbGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000873	0.00165	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000867	0.00164	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.000855	0.00162	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000848	0.00161	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.000837	0.00159	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00083	0.00157	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000823	0.00156	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000823	0.00156	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000823	0.00156	CbGpPWpGaD
Carboprost Tromethamine—Asthenia—Metformin—polycystic ovary syndrome	0.000816	0.0171	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000806	0.00153	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000806	0.00153	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000806	0.00153	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000801	0.00152	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000784	0.00148	CbGpPWpGaD
Carboprost Tromethamine—Diarrhoea—Metformin—polycystic ovary syndrome	0.000778	0.0163	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00077	0.00146	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000754	0.00143	CbGpPWpGaD
Carboprost Tromethamine—Dizziness—Metformin—polycystic ovary syndrome	0.000752	0.0158	CcSEcCtD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000747	0.00142	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.000733	0.00139	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000732	0.00139	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000728	0.00138	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000727	0.00138	CbGpPWpGaD
Carboprost Tromethamine—Vomiting—Metformin—polycystic ovary syndrome	0.000723	0.0152	CcSEcCtD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.000717	0.00136	CbGpPWpGaD
Carboprost Tromethamine—Rash—Metformin—polycystic ovary syndrome	0.000717	0.015	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Metformin—polycystic ovary syndrome	0.000716	0.015	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000713	0.00135	CbGpPWpGaD
Carboprost Tromethamine—Headache—Metformin—polycystic ovary syndrome	0.000712	0.0149	CcSEcCtD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000712	0.00135	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Metformin—polycystic ovary syndrome	0.000675	0.0142	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000674	0.00128	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000666	0.00126	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000663	0.00126	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000661	0.00125	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00066	0.00125	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000652	0.00124	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000649	0.00123	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000647	0.00123	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000607	0.00115	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000602	0.00114	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000594	0.00112	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00059	0.00112	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000584	0.00111	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NPB—polycystic ovary syndrome	0.000583	0.0011	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000577	0.00109	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000572	0.00108	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NPB—polycystic ovary syndrome	0.00057	0.00108	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000565	0.00107	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000564	0.00107	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000558	0.00106	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000552	0.00105	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000551	0.00104	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000546	0.00103	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000541	0.00102	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000539	0.00102	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00053	0.001	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000529	0.001	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000527	0.000998	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000524	0.000993	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000519	0.000983	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000517	0.00098	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000516	0.000977	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000516	0.000977	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000513	0.000972	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000512	0.00097	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000507	0.000959	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000505	0.000957	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000501	0.00095	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000491	0.00093	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000486	0.000921	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000486	0.000921	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000481	0.000911	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000476	0.000901	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000476	0.000901	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000468	0.000887	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000459	0.000869	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000458	0.000867	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000455	0.000861	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000448	0.000848	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000445	0.000843	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000441	0.000836	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000432	0.000819	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000429	0.000814	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.00042	0.000796	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000419	0.000793	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.00041	0.000776	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000391	0.00074	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000382	0.000724	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000381	0.000722	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000373	0.000706	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000356	0.000674	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000348	0.00066	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000348	0.00066	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000346	0.000655	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000341	0.000646	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000339	0.000642	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000335	0.000634	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000327	0.00062	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000325	0.000617	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000319	0.000603	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—FST—polycystic ovary syndrome	0.000317	0.000601	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000315	0.000597	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000313	0.000593	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—FST—polycystic ovary syndrome	0.00031	0.000588	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—LHB—polycystic ovary syndrome	0.00031	0.000586	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000309	0.000585	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000307	0.000581	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000303	0.000574	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000303	0.000573	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000296	0.000561	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000293	0.000555	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000292	0.000554	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SCT—polycystic ovary syndrome	0.00029	0.00055	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000287	0.000543	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000286	0.000542	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000286	0.000542	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000284	0.000538	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00028	0.000531	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000277	0.000524	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000272	0.000515	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000271	0.000513	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—RBP4—polycystic ovary syndrome	0.00027	0.000511	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000269	0.000509	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000266	0.000504	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000266	0.000503	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000264	0.0005	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000263	0.000498	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00026	0.000492	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000252	0.000477	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000248	0.00047	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000246	0.000467	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000243	0.00046	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—INSR—polycystic ovary syndrome	0.000237	0.00045	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000232	0.00044	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000226	0.000427	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000222	0.000421	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000221	0.000418	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PGR—polycystic ovary syndrome	0.00022	0.000416	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000217	0.000412	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000215	0.000408	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000204	0.000387	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000204	0.000387	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.0002	0.000379	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.0002	0.000379	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000197	0.000373	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000195	0.000369	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000193	0.000365	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000191	0.000362	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.00019	0.00036	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000189	0.000359	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000186	0.000353	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000185	0.000351	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NGFR—polycystic ovary syndrome	0.00018	0.000341	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000179	0.000339	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PRL—polycystic ovary syndrome	0.000178	0.000338	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000176	0.000334	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000175	0.000332	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000175	0.000331	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000172	0.000326	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000169	0.00032	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000168	0.000319	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000166	0.000314	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000157	0.000297	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000154	0.000291	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000149	0.000283	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000147	0.000278	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000146	0.000277	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000144	0.000272	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000126	0.000238	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000123	0.000233	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—LEP—polycystic ovary syndrome	0.000123	0.000233	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—LEP—polycystic ovary syndrome	0.00012	0.000228	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IRS1—polycystic ovary syndrome	0.00011	0.000208	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000107	0.000203	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—POMC—polycystic ovary syndrome	0.000106	0.0002	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—INS—polycystic ovary syndrome	0.000105	0.000199	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000103	0.000196	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—INS—polycystic ovary syndrome	0.000103	0.000195	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000102	0.000192	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000102	0.000192	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IGF1—polycystic ovary syndrome	9.95e-05	0.000188	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—AKT2—polycystic ovary syndrome	9.94e-05	0.000188	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.65e-05	0.000183	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.44e-05	0.000179	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—IL6—polycystic ovary syndrome	7.77e-05	0.000147	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—IL6—polycystic ovary syndrome	7.61e-05	0.000144	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.64e-05	0.000126	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.5e-05	0.000123	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—IL6—polycystic ovary syndrome	4.59e-05	8.69e-05	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—IL6—polycystic ovary syndrome	4.49e-05	8.51e-05	CbGpPWpGaD
